These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20469972)

  • 1. Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.
    Jayabose S; Dunbar J; Nowicki TS; Tugal O; Ozkaynak MF; Sandoval C
    Pediatr Hematol Oncol; 2011 Mar; 28(2):167-72. PubMed ID: 20469972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.
    Bhagirath VC; Kelton JG; Moore J; Arnold DM
    Transfusion; 2012 Dec; 52(12):2517-23. PubMed ID: 22486316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
    Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Yomtovian R; Niklinski W; Silver B; Sarode R; Tsai HM
    Br J Haematol; 2004 Mar; 124(6):787-95. PubMed ID: 15009067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Montoya RC; Poiesz BJ
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):338-41. PubMed ID: 22498981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
    Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term remission of recurrent thrombotic thrombocytopenic purpura (TTP) after Rituximab in children and young adults.
    Wieland I; Kentouche K; Jentzsch M; Lothschütz D; Graf N; Sykora KW
    Pediatr Blood Cancer; 2015 May; 62(5):823-9. PubMed ID: 25623397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.
    Kosugi S; Matsumoto M; Ohtani Y; Take H; Ishizashi H; Fujimura Y; Kuyama J
    Int J Hematol; 2005 Jun; 81(5):433-6. PubMed ID: 16158827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.
    Ling HT; Field JJ; Blinder MA
    Am J Hematol; 2009 Jul; 84(7):418-21. PubMed ID: 19507208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.
    Yates S; Matevosyan K; Rutherford C; Shen YM; Sarode R
    Transfusion; 2014 Aug; 54(8):2064-7. PubMed ID: 24655327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection.
    Mak SK; Lo KY; Lo MW; Chan SF; Lo KC; Wong YY; Tong GM; Wong PN; Ma ES; Wong AK
    Hong Kong Med J; 2009 Jun; 15(3):201-8. PubMed ID: 19494376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports.
    Iioka F; Shimomura D; Ishii T; Maesako Y; Ohgoe K; Nakamura F; Matsuo S; Ohno H
    Int J Hematol; 2012 Oct; 96(4):506-12. PubMed ID: 22878941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
    Ojeda-Uribe M; Brunot A; Issler M
    Rev Med Chil; 2005 Nov; 133(11):1349-54. PubMed ID: 16446859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab.
    Goyal J; Adamski J; Lima JL; Marques MB
    J Clin Apher; 2013 Dec; 28(6):390-4. PubMed ID: 23857472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM; Uener J; Hallek M; Scheid C
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature.
    Elliott MA; Heit JA; Pruthi RK; Gastineau DA; Winters JL; Hook CC
    Eur J Haematol; 2009 Oct; 83(4):365-72. PubMed ID: 19508684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
    Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
    Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report.
    Saleem R; Rogers ZR; Neunert C; George JN
    Transfusion; 2019 Mar; 59(3):921-926. PubMed ID: 30548440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.